Point72 Asset Management
OPRX icon

Point72 Asset Management’s OptimizeRx OPRX Stock Holding History

Point72 Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,965
Closed -$147K – 4286
2025
Q4 		$147K Buy
+11,965
New +$196K ﹤0.01% 3693
2024
Q1 		– Sell
-77,520
Closed -$1.11M – 2502
2023
Q4 		$1.11M Buy
+77,520
New +$744K ﹤0.01% 1375
2023
Q3 		– Sell
-461,716
Closed -$6.6M – 2766
2023
Q2 		$6.6M Sell
461,716
-14,476
-3% -$206K 0.02% 726
2023
Q1 		$6.97M Buy
+476,192
New +$7.97M 0.02% 661
2022
Q1 		– Sell
-145,100
Closed -$9.01M – 1330
2021
Q4 		$9.01M Buy
+145,100
New +$11M 0.04% 538

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's OPRX Position: Q1 2026 in Review

Point72 Asset Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 11,965 shares — an estimated $147K sold.

Point72 Asset Management first reported a position in OPRX in Q4 2021 and held it in 5 quarters. The position peaked at $9.01M in Q4 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Point72 Asset Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 11,965 OptimizeRx shares in Q1 2026, an estimated $147K.
  • Point72 Asset Management first reported a position in OptimizeRx in Q4 2021 and held it in 5 quarters.
  • Point72 Asset Management's OptimizeRx position peaked at $9.01M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.